2019

1. Efficacy, immunogenicity, and safety of a quadrivalent inactivated influenza vaccine in children aged 6–35 months: A multi-season randomised placebo-controlled trial in the Northern and Southern Hemispheres

   Vaccine, Vol. 37, Núm. 13, pp. 1876-1884